Salud financiera de hoja de balance de AlzChem Group
Salud financiera controles de criterios 6/6
AlzChem Group tiene un patrimonio de accionistas total de €163.6M y una deuda total de €57.5M, lo que sitúa su ratio deuda-patrimonio en 35.2%. Sus activos y pasivos totales son €424.7M y €261.1M respectivamente. El BAIT de AlzChem Group es de €53.8M, por lo que su ratio de cobertura de intereses es de 13.4. Tiene efectivo e inversiones a corto plazo que ascienden a €11.9M.
Información clave
0%
Ratio deuda-patrimonio
€0
Deuda
| Ratio de cobertura de intereses | 17.8x |
| Efectivo | €36.00m |
| Patrimonio | €179.02m |
| Total pasivo | €268.79m |
| Activos totales | €447.81m |
Actualizaciones recientes sobre salud financiera
Recent updates
AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising
May 08
Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being
May 01AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 26Is AlzChem Group (ETR:ACT) A Risky Investment?
Apr 11AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20
Mar 29The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More
Mar 07Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching
Nov 01Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?
Oct 12AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
May 06AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment
May 05AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05
Apr 05AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
Mar 04AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year
Apr 24AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00
Mar 29AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00
Feb 27AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 23Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?
Jun 10At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?
Apr 07AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?
Mar 23AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price
Mar 10Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 24Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)
Feb 11
Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year
Aug 07Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?
Jul 20Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?
Jul 03Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (€216.6M) de ACT superan a sus pasivos a corto plazo (€82.6M).
Pasivo a largo plazo: Los activos a corto plazo de ACT (€216.6M) superan a sus pasivos a largo plazo (€178.5M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ACT está libre de deudas.
Reducción de la deuda: ACT no tenía deudas hace 5 años.
Cobertura de la deuda: ACT no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.
Cobertura de intereses: ACT no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.